A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis

A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options, according to results of a Doctors Without Borders/Médecins Sans Frontières (MSF) study published in the New England Journal of Medicine today. These findings come from MSF’s TB PRACTECAL, the first-ever multi-country, randomized, controlled clinical trial to…

Panoramic Trial Finds Molnupiravir Does Not Reduce Hospitalisation

Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with…

African Leaders and Global Health Experts Convene in Rwanda for the 2nd International Conference on Public Health in Africa, CPHIA 2022

The 2nd International Conference on Public Health in Africa (CPHIA 2022), in Kigali, Rwanda, at the Kigali Convention Centre kicks off today with African Heads of State, ministers of health, and leading researchers and scientists scheduled to give remarks during three days of official sessions. The conference, which is taking place from 13-15 December, is…

THE LANCET: One in eight deaths in 2019 linked to bacterial infections, the second leading cause of death globally

Common bacterial infections were the second leading cause of death in 2019, and were linked to one in eight deaths globally, according to an analysis published in The Lancet. There were 7.7 million deaths in 2019 associated with 33 common bacterial infections, with five bacteria alone connected to more than half of all deaths. The…

COVID-19 burden lessens in Africa, vigilance crucial as year-end season begins

While Africa is witnessing its lowest level of new COVID-19 cases since the onset of the pandemic, a recent four-week rise—the first such sustained increase in four months—underscores the criticality of maintaining vigilance as the end-year holiday seasons sets in. The continent recorded a four-week long rise until 20 November, but the number of new…

Faith-based organisations affirm commitment to build capacity in family planning

In preparation for the upcoming International Conference on Family Planning (ICFP), members of the faith community are reaffirming their commitment to build the capacities of faith-based organizations in family planning advocacy.  The ICFP Faith Subcommittee will hold a pre-conference on November 13 that will unpack tools and strategies that can be used to engage religious leaders, youth and…

U.S. Ambassador Natalie E. Brown at 2022 National HIV and AIDS Symposium Remarks

The United States government recognizes that a healthy population is the foundation for a country’s social and economic development.   Almost 20 years ago on January 28, 2003, while announcing the President’s Emergency Plan for AIDS Relief (PEPFAR), then U.S. President George W. Bush said, “We must remember our calling, as a blessed country, to…

A new weapon against antibiotic-resistant bacteria

A team from the University of Geneva (UNIGE) has discovered that edoxudine, an anti-herpes molecule discovered in the 60s, weakens the protective surface of Klebsiella bacteria and makes them easier to eliminate for immune cells. These results can be read in the journal PLOS ONE.  Klebsiella pneumoniae causes many respiratory, intestinal and urinary tract infections.…